http://unclineberger.org The latest information about UNC Lineberger Comprehensive Cancer Center - including important breakthroughs in cancer research, treatment and prevention - and the University Cancer Research Fund (UCRF). http://unclineberger.org/news/colon-cancer-therapy-comparative-effectiveness-study http://unclineberger.org/news/colon-cancer-therapy-comparative-effectiveness-study In the first of their studies to be published, the Consortium reports in the January 9 online issue of the Journal of the National Cancer Institute that adding the drug oxaliplatin to the standard of care chemotherapy 5-fluorouracil (5FU) is associated with better survival among patients receiving adjuvant colon cancer treatment in the community. http://unclineberger.org/news/colon-cancer-therapy-comparative-effectiveness-study http://unclineberger.org/news/triangle-bladder-cancer-support-group http://unclineberger.org/news/triangle-bladder-cancer-support-group Bladder cancer patients in the Triangle area are not alone. They have a monthly group where "true loving support for each other" is shared, says David Langham, a bladder cancer survivor and one of the organizers of the group. http://unclineberger.org/news/triangle-bladder-cancer-support-group http://unclineberger.org/news/tepper-oneil-author-rectal-cancer-editorial http://unclineberger.org/news/tepper-oneil-author-rectal-cancer-editorial UNC Lineberger GI Oncology program directors Joel Tepper, MD, and Bert O'Neil, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Tepper is the Hector McLean Distinguished Professor of Cancer Research. O'Neil is associate professor of medicine. http://unclineberger.org/news/tepper-oneil-author-rectal-cancer-editorial http://unclineberger.org/news/tomotherapy http://unclineberger.org/news/tomotherapy Lawrence Marks, MD, chair of UNC's department of radiation oncology and a UNC Lineberger member, is quoted in the article "TomoTherapy offers safer radiation" published in today's issue of The News and Observer. http://unclineberger.org/news/tomotherapy http://unclineberger.org/news/first-major-genetic-mutation-associated-with-hereditary-prostate-cancer-risk http://unclineberger.org/news/first-major-genetic-mutation-associated-with-hereditary-prostate-cancer-risk After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease http://unclineberger.org/news/first-major-genetic-mutation-associated-with-hereditary-prostate-cancer-risk